Celldex Therapeutics, Inc. (NASDAQ:CLDX) Shares Bought by Swiss National Bank
Swiss National Bank raised its position in Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 1.2% in the 4th quarter, Holdings Channel reports. The fund owned 117,300 shares of the biopharmaceutical company’s stock after acquiring an additional 1,400 shares during the period. Swiss National Bank’s holdings in Celldex Therapeutics were worth $2,964,000 as of its […]
